Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.

Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH.

Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.

2.

Deactivation of pacemakers and implantable cardioverter-defibrillators.

Kramer DB, Mitchell SL, Brock DW.

Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):290-9. doi: 10.1016/j.pcad.2012.09.003. Review.

3.

Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.

Gura MT.

AACN Adv Crit Care. 2015 Oct-Dec;26(4):356-63. doi: 10.1097/NCI.0000000000000111. Review.

PMID:
26484996
4.

Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Chamsi-Pasha H, Chamsi-Pasha MA, Albar MA.

Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8. Review.

PMID:
24619521
5.

Ethical considerations for turning off pacemakers and defibrillators.

Karches KE, Sulmasy DP.

Card Electrophysiol Clin. 2015 Sep;7(3):547-55. doi: 10.1016/j.ccep.2015.05.012. Epub 2015 Jun 24. Review.

PMID:
26304534
6.

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.

Wright GA, Klein GJ, Gula LJ.

Curr Opin Cardiol. 2013 Jan;28(1):43-9. doi: 10.1097/HCO.0b013e32835b0b3b. Review.

PMID:
23128499
7.

The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D.

Dtsch Arztebl Int. 2012 Aug;109(33-34):535-41. doi: 10.3238/arztebl.2012.0535. Epub 2012 Aug 20. Review.

8.

Withdrawal of cardiac medications and devices.

Wiegand DL, Kalowes PG.

AACN Adv Crit Care. 2007 Oct-Dec;18(4):415-25. Review.

PMID:
17978616
9.

Within you/without you: biotechnology, ontology, and ethics.

Sulmasy DP.

J Gen Intern Med. 2008 Jan;23 Suppl 1:69-72. doi: 10.1007/s11606-007-0326-x. Review.

11.

Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.

Morgenweck CJ.

Curr Opin Anaesthesiol. 2013 Apr;26(2):171-5. doi: 10.1097/ACO.0b013e32835e8349. Review.

PMID:
23403711
12.

[End-of-life Decisions].

Erbguth FJ, Erbguth L.

Dtsch Med Wochenschr. 2016 Sep;141(20):1484-1496. Epub 2016 Oct 4. Review. German.

PMID:
27701697
13.

Pacemaker and defibrillator deactivation in competent hospice patients: an ethical consideration.

Ballentine JM.

Am J Hosp Palliat Care. 2005 Jan-Feb;22(1):14-9. Review.

PMID:
15736602
14.

Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.

Russo JE.

Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91. Review.

PMID:
21926561
15.

[Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Ladwig KH, Ischinger NF, Ronel J, Kolb C.

Herzschrittmacherther Elektrophysiol. 2011 Sep;22(3):151-6. doi: 10.1007/s00399-011-0138-x. Review. German.

PMID:
21769624
16.

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.

Padeletti L, Arnar DO, Boncinelli L, Brachman J, Camm JA, Daubert JC, Hassam SK, Deliens L, Glikson M, Hayes D, Israel C, Lampert R, Lobban T, Raatikainen P, Siegal G, Vardas P; Reviewers:., Kirchhof P, Becker R, Cosio F, Loh P, Cobbe S, Grace A, Morgan J; EuropeanHeart RhythmAssociation.; Heart Rhythm Society..

Europace. 2010 Oct;12(10):1480-9. doi: 10.1093/europace/euq275. Epub 2010 Jul 30. Erratum in: Europace. 2011 Apr;13(4):599. Kassam, Sarah [corrected to Hassam, Sarah K].

PMID:
20675674
17.
19.

HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.

Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology.; American Geriatrics Society.; American Academy of Hospice and Palliative Medicine.; American Heart Association.; European Heart Rhythm Association.; Hospice and Palliative Nurses Association..

Heart Rhythm. 2010 Jul;7(7):1008-26. doi: 10.1016/j.hrthm.2010.04.033. Epub 2010 May 14. No abstract available.

PMID:
20471915
20.

Deactivation of implantable cardioverter-defibrillators at end of life.

Pettit SJ, Jackson CE, Gardner RS.

Future Cardiol. 2013 Nov;9(6):885-96. doi: 10.2217/fca.13.81. Review.

PMID:
24180544

Supplemental Content

Support Center